Invasive non-typhoidal Salmonella infections in sub-Saharan Africa: a systematic review on antimicrobial resistance and treatment
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Background: Non-typhoidal Salmonella(NTS) are a frequent cause of invasive infections in sub-Saharan Africa. They are frequently multidrug resistant (co-resistant to ampicillin, trimethoprim-sulfamethoxazole, and chloramphenicol), and resistance to third-generation cephalosporin and fluoroquinolone non-susceptibility have been reported. Third-generation cephalosporins and fluoroquinolones are often used to treat invasive NTS infections, but azithromycin might be an alternative. However, data on antibiotic treatment efficacy in invasive NTS infections are lacking. In this study, we aimed to assess the spatiotemporal distribution of antimicrobial resistance in invasive NTS infections in sub-Saharan Africa and to describe the available evidence and recommendations on antimicrobial treatment. Methods: We conducted a systematic review of all available literature on antimicrobial resistance and treatment in invasive NTS infections. We performed a random effects meta-analysis to assess the temporal distribution of multidrug resistance, third-generation cephalosporin resistance, and fluoroquinolone non-susceptibility. We mapped these data to assess the spatial distribution. We provided a narrative synthesis of the available evidence and recommendations on antimicrobial treatment. Results: Since 2001, multidrug resistance was observed in 75% of NTS isolates from all sub-Saharan African regions (95% confidence interval, 70–80% and 65–84%). Third-generation cephalosporin resistance emerged in all sub-Saharan African regions and was present in 5% (95% confidence interval, 1–10%) after 2010. Fluoroquinolone non-susceptibility emerged in all sub-Saharan African regions but did not increase over time. Azithromycin resistance was reported in DR Congo. There were no reports on carbapenem resistance. We did not find high-quality evidence on the efficacy of antimicrobial treatment. There were no supranational guidelines. The “Access group” antibiotics ampicillin, trimethoprim-sulfamethoxazole, and chloramphenicol and “Watch group” antibiotics ceftriaxone, cefotaxime, and ciprofloxacin were recommended as the first-choice antibiotics in national guidelines or reviews. These also recommended (a switch to) oral fluoroquinolones or azithromycin. Conclusions: In addition to the widespread multidrug resistance in invasive NTS infections in sub-Saharan Africa, resistance to third-generation cephalosporins and fluoroquinolone non-susceptibility was present in all regions. There was a lack of data on the efficacy of antimicrobial treatment in these infections, and supranational evidence-based guidelines were absent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449 · cited 3×
“The first study that reported the proportion of MDR according to the current definition of MDR for NTS [5, 23] was published in 2012 [33].”
BackgroundMethodJames, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Munn, Z., Moola, S., Lisy, K., Riitano, D., & Tufanaru, C. (2015) · International Journal of Evidence-Based Healthcare · doi:10.1097/xeb.0000000000000054 · Cited by 3,131 · cited 1×
“For research question 1, the MICRO checklist [11] and the Joanna Briggs Institute Critical Appraisal Checklist for Studies Reporting Prevalence Data [12] were used.”
MethodGuarino, A., Ashkenazi, S., Gendrel, D., Lo Vecchio, A., Shamir, R., & Szajewska, H. (2014) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000375 · Cited by 935
Stanaway, J. D., Parisi, A., Sarkar, K., Blacker, B. F., Reiner, R. C., Hay, S. I., Nixon, M. R., Dolecek, C., James, S. L., Mokdad, A. H., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30418-9 · Cited by 645
Innovations in the systematic review of text and opinion
McArthur, A., Klugárová, J., Yan, H., & Florescu, S. (2015) · International Journal of Evidence-Based Healthcare · doi:10.1097/xeb.0000000000000060 · Cited by 254 · cited 1×
“For guidelines, we used the AGREE II checklist [14], and for recommendations in expert opinion papers or reviews, the Joanna Briggs Institute Critical Appraisal Checklist for Text and Opinion Papers [15].”
MethodSalmonella Infections in Childhood
Bula-Rudas, F. J., Rathore, M. H., & Maraqa, N. F. (2015) · Advances in Pediatrics · doi:10.1016/j.yapd.2015.04.005 · Cited by 175 · cited 1×
“For osteomyelitis and other focal infections, 4–6 weeks of antibiotics were generally recommended [89, 91, 95, 106, 111, 112], although 2–4 weeks of fluoroquinolones or C3G were also suggested [114].”
BackgroundPost, A. S., Diallo, S. N., Guiraud, I., Lompo, P., Tahita, M. C., Maltha, J., Van Puyvelde, S., Mattheus, W., Ley, B., Thriemer, K., et al. (2019) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0007782 · Cited by 58 · cited 1×
“However, increasing evidence supports a human instead of zoonotic transmission of invasive NTS in sub-Saharan Africa [63, 142] (Phoba M-F, Barbé B, Ley B, Van Puyvelde S, Post A, Mattheus W, et al.”
BackgroundSelf-citation
Cited by
Marchello, C. S., Birkhold, M., Crump, J. A., Martin, L. B., Ansah, M. O., Breghi, G., Canals, R., Fiorino, F., Gordon, M. A., Kim, J.-H., et al. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00615-0 · Cited by 258
Self-citationStepwise evolution of Salmonella Typhimurium ST313 causing bloodstream infection in Africa
Pulford, C. V., Perez-Sepulveda, B. M., Canals, R., Bevington, J. A., Bengtsson, R. J., Wenner, N., Rodwell, E. V., Kumwenda, B., Zhu, X., Bennett, R. J., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00836-1 · Cited by 151
Park, S. E., Pham, D. T., Pak, G. D., Panzner, U., Maria Cruz Espinoza, L., von Kalckreuth, V., Im, J., Mogeni, O. D., Schütt-Gerowitt, H., Crump, J. A., et al. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2021-005659 · Cited by 50
Donkor, E. S., Muhsen, K., Johnson, S. A. M., Kotey, F. C. N., Dayie, N. T. K. D., Tetteh-Quarcoo, P. B., Tette, E. M. A., Osei, M.-M., Egyir, B., Nii-Trebi, N. I., et al. (2023) · Antibiotics · doi:10.3390/antibiotics12020255 · Cited by 46
“[42], in a meta-analysis that assessed AMR in invasive NTS in sub-Saharan Africa, defined multidrug resistance based on the antibiotic, ampicillin, trimethoprim-sulfamethoxazole, or chloramphenicol.”
BackgroundInfluential
Metadata
- Authors
- Tack, B., Vanaenrode, J., Verbakel, J. Y., Toelen, J., & Jacobs, J.
- Venue
- BMC Medicine
- Published
- 2020-07-17
- Volume
- 18
- Issue
- 1
- Pages
- 212-212
- ISSN
- 1741-7015 (ISSN-L)
- OpenAlex
- W3042408010
- Cited by
- 145
- References
- 11
- FWCI
- 2.38
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Invasive non-typhoidal Salmonella infections in sub-Saharan Africa: a systematic review on antimicrobial resistance and treatment. https://app.cochat.ai/papers/10.1186/s12916-020-01652-4
- The paper
- Tack, B., Vanaenrode, J., Verbakel, J. Y., Toelen, J., & Jacobs, J. (2020). Invasive non-typhoidal Salmonella infections in sub-Saharan Africa: a systematic review on antimicrobial resistance and treatment. BMC Medicine. https://doi.org/10.1186/s12916-020-01652-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.